PeptideDB

SARS-CoV-2-IN-44

CAS: 1311271-71-2 F: C18H16O5 W: 312.32

SARS-CoV-2-IN-44, a inhibitor of SARS-CoV-2, inhibits viral replication, with an EC50 of 0.6μM. SARS-CoV-2-IN-44 has no
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity SARS-CoV-2-IN-44, a inhibitor of SARS-CoV-2, inhibits viral replication, with an EC50 of 0.6μM. SARS-CoV-2-IN-44 has no evident cytotoxic effect in Calu-3 cells and can be used for antiviral research[1].
Invitro SARS-CoV-2-IN-44 (Compound 8m) (0-250 μΜ;72 小时) 对 Calu-3 细胞无明显细胞毒性作用,即使在 250 μM 时,毒性也较低[1]。 Cell Cytotoxicity Assay[1] Cell Line:
Name SARS-CoV-2-IN-44
CAS 1311271-71-2
Formula C18H16O5
Molar Mass 312.32
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Caleffi GS, et.al. Aurones: A Promising Scaffold to Inhibit SARS-CoV-2 Replication. J Nat Prod. 2023 Jun 23;86(6):1536-1549.